Cite
Hoyer H, Mehlhorn G, Scheungraber C, et al. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133309.
Hoyer, H., Mehlhorn, G., Scheungraber, C., Hagemann, I., Hirchenhain, C., Woelber, L., Stolte, C., Hampl, M., Scherbring, S., Denecke, A., Bartels, J., Ebert, A. D., Meneder, S., Petzold, A., Heller, T., Heidtke, K. R., Schwarz, E., Stübs, F., Schütze, S., Stange, E. L., Jaeger, A., Martignoni, F., Dellmann, A., Rody, A., Hillemanns, P., Fehm, T., Petry, K. U., Böhmer, G., Schmalfeldt, B., Wimberger, P., Beckmann, M. W., Runnebaum, I. B., & Dürst, M. (2021). Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers, 13(13), . https://doi.org/10.3390/cancers13133309
Hoyer, Heike, et al. "Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133309
Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, Hampl M, Scherbring S, Denecke A, Bartels J, Ebert AD, Meneder S, Petzold A, Heller T, Heidtke KR, Schwarz E, Stübs F, Schütze S, Stange EL, Jaeger A, Martignoni F, Dellmann A, Rody A, Hillemanns P, Fehm T, Petry KU, Böhmer G, Schmalfeldt B, Wimberger P, Beckmann MW, Runnebaum IB, Dürst M. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133309. PMID: 34282754; PMCID: PMC8269020.
Copy
Download .nbib